Exact Mass: 500.208

Fluticasone propionate

C25H31F3O5S (500.1844)

Fluticasone propionate, a medium-potency synthetic corticosteroid, is used topically to relieve inflammatory and pruritic symptoms of dermatoses and psoriasis, intranasally to manage symptoms of allergic and non-allergic rhinitis, and orally for the treatment of asthma. Fluticasone propionate binds to the glucocorticoid receptor. Unbound corticosteroids cross the membranes of cells such as mast cells and eosinophils, binding with high affinity to glucocorticoid receptors (GR). The results include alteration of transcription and protein synthesis, a decreased release of leukocytic acid hydrolases, reduction in fibroblast proliferation, prevention of macrophage accumulation at inflamed sites, reduction of collagen deposition, interference with leukocyte adhesion to the capillary wall, reduction of capillary membrane permeability and subsequent edema, reduction of complement components, inhibition of histamine and kinin release, and interference with the formation of scar tissue. In the management of asthma, the glucocorticoid receptor complexes down-regulates proinflammatory mediators such as interleukin-(IL)-1, 3, and 5, and up-regulates anti-inflammatory mediators such as IκB (inhibits NF-κB). Corticosteroids are the most effective anti-inflammatory therapy for allergic diseases. They are believed to inhibit T helper cell type 2 (TH2 T-cell) activation through increased immunoregulatory T cell (CD4+CD25+) suppression (PMID: 15316506). Fluticasone propionate is marketed under the brand name Flixotide and Flixonase by Allen & Hanburys, and Flovent and Flonase by GlaxoSmithKline. Fluticasone propionate is only found in individuals that have used or taken this drug. Hanburys and Flovent and Flonase by GlaxoSmithKline.; Fluticasone propionate is a potent glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. It is marketed with the brand name Flixotide and Flixonase by Allen & Fluticasone is a potent glucocorticoid often prescribed as treatment for asthma and allergic rhinitis. D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Austin

C27H32O9 (500.2046)

Austin is a mycotoxin produced by the food storage mould (Aspergillus ustus). These are sesquiterpenes containing a lactone ring. Mycotoxin production by the food storage mould (Aspergillus ustus).

Isoaustin

C27H32O9 (500.2046)

Isoaustin is a mycotoxin from of Penicillium diversu

Artonol C

C30H28O7 (500.1835)

Artonol C is found in breadfruit. Artonol C is a constituent of the bark of Artocarpus communis (breadfruit) Constituent of the bark of Artocarpus communis (breadfruit). Artonol C is found in breadfruit and fruits.

Tritoqualine

C26H32N2O8 (500.2159)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists Tritoqualine is an H1-antihistamine. C471 - Enzyme Inhibitor

D-Phenylalanyl-N-[(3s)-6-Carbamimidamido-1-Chloro-2-Oxohexan-3-Yl]-L-Phenylalaninamide

C25H33ClN6O3 (500.2303)

Phenylalanyl-phenylalanyl-arginine chloromethyl ketone

C25H33ClN6O3 (500.2303)

Galactoarabinan

C20H36O14 (500.2105)

L-Tyrosine, N-(2-(methoxycarbonyl)phenyl)-O-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-

C29H28N2O6 (500.1947)

Rolapitant

C25H26F6N2O2 (500.1898)

Verrucarin L

C27H32O9 (500.2046)

Xylogranatin I

C27H32O9 (500.2046)

Quadrangularin C

C30H28O7 (500.1835)

Atalantin

C27H32O9 (500.2046)

Maculalactone F

C34H28O4 (500.1987)

Verrucarin M

C27H32O9 (500.2046)

6R,8alpha-Dihydroxycarapin

C27H32O9 (500.2046)

Seguinoside J

C23H32O12 (500.1894)

Myrotoxin A

C27H32O9 (500.2046)

Pedonin

C27H32O9 (500.2046)

Boletocrocin A

C26H32N2O8 (500.2159)

Xylogranatin R

C27H32O9 (500.2046)

Arisanschinin I

C27H32O9 (500.2046)

Benastatin A

C30H28O7 (500.1835)

Euchretin D

C30H28O7 (500.1835)

Paraensidimerin B

C30H32N2O5 (500.2311)

Euchretin E

C30H28O7 (500.1835)

Arisanschinin H

C27H32O9 (500.2046)

Verrucarin B

C27H32O9 (500.2046)

PD 113,325

C27H32O9 (500.2046)

Kopsidine B

C26H32N2O8 (500.2159)

1-O-deacetyl-6-deoxykhayanolide E

C27H32O9 (500.2046)

Artonol C

C30H28O7 (500.1835)

kansuinin A

C24H36O11 (500.2258)

C27H32O9

C27H32O9 (500.2046)

D-Gluconate-Quinidine

C26H32N2O8 (500.2159)

Betulalbuside A

C24H36O11 (500.2258)

3-Oxopteronialactone

C27H32O9 (500.2046)

2-((Z)-hepta-5-en-1,3-diynyl)tetrahydrofuran-2-beta-D-glucopyranosyl(1->2)-beta-D-glucopyranoside|panaxfurayne B

C23H32O12 (500.1894)

Dendrofalconerol B

C30H28O7 (500.1835)

C24H36O11

C24H36O11 (500.2258)

jaborosalactone 3

C28H33ClO6 (500.1966)

2-Dehydroverrucarin A|Dehydroverrucarin A

C27H32O9 (500.2046)

C25H37ClO8

C25H37ClO8 (500.2177)

Orbiculin D

C27H32O9 (500.2046)

A dihydroagarofuran sesquiterpenoid that consists of dihydro-beta-agarofuran substituted by acetoxy group at position 1 and furoyloxy groups at positions 6 and 9 (the 1beta,6alpha,9alpha stereoisomer). Isolated from Celastrus orbiculatus, it exhibits inhibition of both NF-kappaB activation and nitric oxide production.

(3S)-3,7-anhydro-6,7-dehydroericanone 4-beta-D-glucopyranoside

C27H32O9 (500.2046)

Fmoc-L-Val-L-Phe-OMe|ixorapeptide I

C30H32N2O5 (500.2311)

(1R,4S,5R,6R,7R,8R)-3-Oxo-8-<5-(5-acetoxytiglyloxy)-tiglyloxy>-guaia-10(14),11(13)-dien-6,12-olide|(1R,4S,5R,6R,7R,8R)-3-Oxo-8-[5-(5-acetoxytiglyloxy)-tiglyloxy]-guaia-10(14),11(13)-dien-6,12-olide

C27H32O9 (500.2046)

Oxyphysodic acid

C27H32O9 (500.2046)

O-Rutinoside-3-(3-Hydroxypropyl)phthalide|Pedirutinoside

C23H32O12 (500.1894)

Artocommunol CA

C31H32O6 (500.2199)

haperforin B1

C27H32O9 (500.2046)

16-Hydroxy-Verrucarin J

C27H32O9 (500.2046)

Isovaleroyl oxokadsuranol

C27H32O9 (500.2046)

Disinapoylputrescine.

C26H32N2O8 (500.2159)

13鈥樎?Hydroxyverrucarin J

C27H32O9 (500.2046)

dendraol A

C30H28O7 (500.1835)

trijugin B

C27H32O9 (500.2046)

Dodoviscin A

C27H32O9 (500.2046)

dodoviscin A is a natural product found in Dodonaea viscosa with data available.

cipatrijugin G|methyl rel-[(4R,4aS,6R,7aR,8S,11aS,12aR)-4-(furan-3-yl)dodecahydro-6-hydroxy-4a,7a,9,9-tetramethyl-13-methylidene-2,7,10-trioxo-4H-6,12a-methanopyrano[4,3-b][1]benzoxocin-8-yl]acetate

C27H32O9 (500.2046)

formicinuoside C

C23H32O12 (500.1894)

dodovicin D

C27H32O9 (500.2046)

Artorigidin C

C30H28O7 (500.1835)

(1R,2S,4S,5S,6R,7R,9S,10S)-1,2,9,15-tetraacetoxy-4,6-dihydroxy-8-oxodihydro-beta-agarofuran

C23H32O12 (500.1894)

Celephtalide B

C23H32O12 (500.1894)

Lividic acid

C27H32O9 (500.2046)

Leu Cys His Asp

C20H32N6O7S (500.2053)

Dodovisone B

C27H32O9 (500.2046)

Fluticasone propionate

C25H31F3O5S (500.1844)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Austin

C27H32O9 (500.2046)

CONFIDENCE Penicillium nucicola

Tritoqualine

C26H32N2O8 (500.2159)

R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C471 - Enzyme Inhibitor

Fluticasone

C25H31F3O5S (500.1844)

D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents CONFIDENCE standard compound; INTERNAL_ID 2831 D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Ala Phe Thr Tyr

C25H32N4O7 (500.2271)

Ala Phe Tyr Thr

C25H32N4O7 (500.2271)

Ala His His His

C21H28N10O5 (500.2244)

Ala Thr Phe Tyr

C25H32N4O7 (500.2271)

Ala Thr Tyr Phe

C25H32N4O7 (500.2271)

Ala Tyr Phe Thr

C25H32N4O7 (500.2271)

Ala Tyr Thr Phe

C25H32N4O7 (500.2271)

Cys Glu His Ile

C20H32N6O7S (500.2053)

Cys Glu His Leu

C20H32N6O7S (500.2053)

Cys Glu Ile His

C20H32N6O7S (500.2053)

Cys Glu Leu His

C20H32N6O7S (500.2053)

Cys His Glu Ile

C20H32N6O7S (500.2053)

Cys His Glu Leu

C20H32N6O7S (500.2053)

Cys His Ile Glu

C20H32N6O7S (500.2053)

Cys His Lys Asn

C19H32N8O6S (500.2165)

Cys His Leu Glu

C20H32N6O7S (500.2053)

Cys His Asn Lys

C19H32N8O6S (500.2165)

Cys Ile Glu His

C20H32N6O7S (500.2053)

Cys Ile His Glu

C20H32N6O7S (500.2053)

Cys Lys His Asn

C19H32N8O6S (500.2165)

Cys Lys Asn His

C19H32N8O6S (500.2165)

Cys Leu Glu His

C20H32N6O7S (500.2053)

Cys Leu His Glu

C20H32N6O7S (500.2053)

Cys Asn His Lys

C19H32N8O6S (500.2165)

Cys Asn Lys His

C19H32N8O6S (500.2165)

Asp Glu His Thr

C19H28N6O10 (500.1867)

Asp Glu Thr His

C19H28N6O10 (500.1867)

Asp Phe Gly Tyr

C24H28N4O8 (500.1907)

Asp Phe Tyr Gly

C24H28N4O8 (500.1907)

Asp Gly Phe Tyr

C24H28N4O8 (500.1907)

Asp Gly Tyr Phe

C24H28N4O8 (500.1907)

Asp His Glu Thr

C19H28N6O10 (500.1867)

Asp His Met Val

C20H32N6O7S (500.2053)

Asp His Thr Glu

C19H28N6O10 (500.1867)

Asp His Val Met

C20H32N6O7S (500.2053)

Asp Met His Val

C20H32N6O7S (500.2053)

Asp Met Val His

C20H32N6O7S (500.2053)

Asp Thr Glu His

C19H28N6O10 (500.1867)

Asp Thr His Glu

C19H28N6O10 (500.1867)

Asp Val His Met

C20H32N6O7S (500.2053)

Asp Val Met His

C20H32N6O7S (500.2053)

Asp Tyr Phe Gly

C24H28N4O8 (500.1907)

Asp Tyr Gly Phe

C24H28N4O8 (500.1907)

Glu Cys His Ile

C20H32N6O7S (500.2053)

Glu Cys His Leu

C20H32N6O7S (500.2053)

Glu Cys Ile His

C20H32N6O7S (500.2053)

Glu Cys Leu His

C20H32N6O7S (500.2053)

Glu Asp His Thr

C19H28N6O10 (500.1867)

Glu Asp Thr His

C19H28N6O10 (500.1867)

Glu Glu His Ser

C19H28N6O10 (500.1867)

Glu Glu Ser His

C19H28N6O10 (500.1867)

Glu His Cys Ile

C20H32N6O7S (500.2053)

Glu His Cys Leu

C20H32N6O7S (500.2053)

Glu His Asp Thr

C19H28N6O10 (500.1867)

Glu His Glu Ser

C19H28N6O10 (500.1867)

Glu His Ile Cys

C20H32N6O7S (500.2053)

Glu His Leu Cys

C20H32N6O7S (500.2053)

Glu His Ser Glu

C19H28N6O10 (500.1867)

Glu His Thr Asp

C19H28N6O10 (500.1867)

Glu Ile Cys His

C20H32N6O7S (500.2053)

Glu Ile His Cys

C20H32N6O7S (500.2053)

Glu Leu Cys His

C20H32N6O7S (500.2053)

Glu Leu His Cys

C20H32N6O7S (500.2053)

Glu Pro Gln Gln

C20H32N6O9 (500.2231)

Glu Gln Pro Gln

C20H32N6O9 (500.2231)

Glu Gln Gln Pro

C20H32N6O9 (500.2231)

Glu Ser Glu His

C19H28N6O10 (500.1867)

Glu Ser His Glu

C19H28N6O10 (500.1867)

Glu Thr Asp His

C19H28N6O10 (500.1867)

Glu Thr His Asp

C19H28N6O10 (500.1867)

Phe Ala Thr Tyr

C25H32N4O7 (500.2271)

Phe Ala Tyr Thr

C25H32N4O7 (500.2271)

Phe Asp Gly Tyr

C24H28N4O8 (500.1907)

Phe Asp Tyr Gly

C24H28N4O8 (500.1907)

Phe Phe Gly Met

C25H32N4O5S (500.2093)

Phe Phe Met Gly

C25H32N4O5S (500.2093)

Phe Phe Ser Thr

C25H32N4O7 (500.2271)

Phe Phe Thr Ser

C25H32N4O7 (500.2271)

Phe Gly Asp Tyr

C24H28N4O8 (500.1907)

Phe Gly Phe Met

C25H32N4O5S (500.2093)

Phe Gly Met Phe

C25H32N4O5S (500.2093)

Phe Gly Tyr Asp

C24H28N4O8 (500.1907)

Phe Met Phe Gly

C25H32N4O5S (500.2093)

Phe Met Gly Phe

C25H32N4O5S (500.2093)

Phe Ser Phe Thr

C25H32N4O7 (500.2271)

Phe Ser Thr Phe

C25H32N4O7 (500.2271)

Phe Thr Ala Tyr

C25H32N4O7 (500.2271)

Phe Thr Phe Ser

C25H32N4O7 (500.2271)

Phe Thr Ser Phe

C25H32N4O7 (500.2271)

Phe Thr Tyr Ala

C25H32N4O7 (500.2271)

Phe Tyr Ala Thr

C25H32N4O7 (500.2271)

Phe Tyr Asp Gly

C24H28N4O8 (500.1907)

Phe Tyr Gly Asp

C24H28N4O8 (500.1907)

Phe Tyr Thr Ala

C25H32N4O7 (500.2271)

Gly Asp Phe Tyr

C24H28N4O8 (500.1907)

Gly Asp Tyr Phe

C24H28N4O8 (500.1907)

Gly Phe Asp Tyr

C24H28N4O8 (500.1907)

Gly Phe Phe Met

C25H32N4O5S (500.2093)

Gly Phe Met Phe

C25H32N4O5S (500.2093)

Gly Phe Tyr Asp

C24H28N4O8 (500.1907)

Gly Met Phe Phe

C25H32N4O5S (500.2093)

Gly Val Tyr Tyr

C25H32N4O7 (500.2271)

Gly Tyr Asp Phe

C24H28N4O8 (500.1907)

Gly Tyr Phe Asp

C24H28N4O8 (500.1907)

Gly Tyr Val Tyr

C25H32N4O7 (500.2271)

Gly Tyr Tyr Val

C25H32N4O7 (500.2271)

His Ala His His

C21H28N10O5 (500.2244)

His Cys Glu Ile

C20H32N6O7S (500.2053)

His Cys Glu Leu

C20H32N6O7S (500.2053)

His Cys Ile Glu

C20H32N6O7S (500.2053)

His Cys Lys Asn

C19H32N8O6S (500.2165)

His Cys Leu Glu

C20H32N6O7S (500.2053)

His Cys Asn Lys

C19H32N8O6S (500.2165)

His Asp Glu Thr

C19H28N6O10 (500.1867)

His Asp Met Val

C20H32N6O7S (500.2053)

His Asp Thr Glu

C19H28N6O10 (500.1867)

His Asp Val Met

C20H32N6O7S (500.2053)

His Glu Cys Ile

C20H32N6O7S (500.2053)

His Glu Cys Leu

C20H32N6O7S (500.2053)

His Glu Asp Thr

C19H28N6O10 (500.1867)

His Glu Glu Ser

C19H28N6O10 (500.1867)

His Glu Ile Cys

C20H32N6O7S (500.2053)

His Glu Leu Cys

C20H32N6O7S (500.2053)

His Glu Ser Glu

C19H28N6O10 (500.1867)

His Glu Thr Asp

C19H28N6O10 (500.1867)

His His Ala His

C21H28N10O5 (500.2244)

His His His Ala

C21H28N10O5 (500.2244)

His Ile Cys Glu

C20H32N6O7S (500.2053)

His Ile Glu Cys

C20H32N6O7S (500.2053)

His Lys Cys Asn

C19H32N8O6S (500.2165)

His Lys Asn Cys

C19H32N8O6S (500.2165)

His Leu Cys Glu

C20H32N6O7S (500.2053)

His Leu Glu Cys

C20H32N6O7S (500.2053)

His Met Asp Val

C20H32N6O7S (500.2053)

His Met Val Asp

C20H32N6O7S (500.2053)

His Asn Cys Lys

C19H32N8O6S (500.2165)

His Asn Lys Cys

C19H32N8O6S (500.2165)

His Ser Glu Glu

C19H28N6O10 (500.1867)

His Thr Asp Glu

C19H28N6O10 (500.1867)

His Thr Glu Asp

C19H28N6O10 (500.1867)

His Val Asp Met

C20H32N6O7S (500.2053)

His Val Met Asp

C20H32N6O7S (500.2053)

Ile Cys Glu His

C20H32N6O7S (500.2053)

Ile Cys His Glu

C20H32N6O7S (500.2053)

Ile Glu Cys His

C20H32N6O7S (500.2053)

Ile Glu His Cys

C20H32N6O7S (500.2053)

Ile His Cys Glu

C20H32N6O7S (500.2053)

Ile His Glu Cys

C20H32N6O7S (500.2053)

Lys Cys His Asn

C19H32N8O6S (500.2165)

Lys Cys Asn His

C19H32N8O6S (500.2165)

Lys His Cys Asn

C19H32N8O6S (500.2165)

Lys His Asn Cys

C19H32N8O6S (500.2165)

Lys Asn Cys His

C19H32N8O6S (500.2165)

Lys Asn His Cys

C19H32N8O6S (500.2165)

Leu Cys Glu His

C20H32N6O7S (500.2053)

Leu Cys His Glu

C20H32N6O7S (500.2053)

Leu Glu Cys His

C20H32N6O7S (500.2053)

Leu Glu His Cys

C20H32N6O7S (500.2053)

Leu His Cys Glu

C20H32N6O7S (500.2053)

Leu His Glu Cys

C20H32N6O7S (500.2053)

Met Asp His Val

C20H32N6O7S (500.2053)

Met Asp Val His

C20H32N6O7S (500.2053)

Met Phe Phe Gly

C25H32N4O5S (500.2093)

Met Phe Gly Phe

C25H32N4O5S (500.2093)

Met Gly Phe Phe

C25H32N4O5S (500.2093)

Met His Asp Val

C20H32N6O7S (500.2053)

Met His Val Asp

C20H32N6O7S (500.2053)

Met Ser Thr Tyr

C21H32N4O8S (500.1941)

Met Ser Tyr Thr

C21H32N4O8S (500.1941)

Met Thr Ser Tyr

C21H32N4O8S (500.1941)

Met Thr Tyr Ser

C21H32N4O8S (500.1941)

Met Val Asp His

C20H32N6O7S (500.2053)

Met Val His Asp

C20H32N6O7S (500.2053)

Met Tyr Ser Thr

C21H32N4O8S (500.1941)

Met Tyr Thr Ser

C21H32N4O8S (500.1941)

Asn Cys His Lys

C19H32N8O6S (500.2165)

Asn Cys Lys His

C19H32N8O6S (500.2165)

Asn His Cys Lys

C19H32N8O6S (500.2165)

Asn His Lys Cys

C19H32N8O6S (500.2165)

Asn Lys Cys His

C19H32N8O6S (500.2165)

Asn Lys His Cys

C19H32N8O6S (500.2165)

Pro Glu Gln Gln

C20H32N6O9 (500.2231)

Pro Gln Glu Gln

C20H32N6O9 (500.2231)

Pro Gln Gln Glu

C20H32N6O9 (500.2231)

Gln Glu Pro Gln

C20H32N6O9 (500.2231)

Gln Glu Gln Pro

C20H32N6O9 (500.2231)

Gln Pro Glu Gln

C20H32N6O9 (500.2231)

Gln Pro Gln Glu

C20H32N6O9 (500.2231)

Gln Gln Glu Pro

C20H32N6O9 (500.2231)

Gln Gln Pro Glu

C20H32N6O9 (500.2231)

Ser Glu Glu His

C19H28N6O10 (500.1867)

Ser Glu His Glu

C19H28N6O10 (500.1867)

Ser Phe Phe Thr

C25H32N4O7 (500.2271)

Ser Phe Thr Phe

C25H32N4O7 (500.2271)

Ser His Glu Glu

C19H28N6O10 (500.1867)

Ser Met Thr Tyr

C21H32N4O8S (500.1941)

Ser Met Tyr Thr

C21H32N4O8S (500.1941)

Ser Thr Phe Phe

C25H32N4O7 (500.2271)

Ser Thr Met Tyr

C21H32N4O8S (500.1941)

Ser Thr Tyr Met

C21H32N4O8S (500.1941)

Ser Tyr Met Thr

C21H32N4O8S (500.1941)

Ser Tyr Thr Met

C21H32N4O8S (500.1941)

Thr Ala Phe Tyr

C25H32N4O7 (500.2271)

Thr Ala Tyr Phe

C25H32N4O7 (500.2271)

Thr Asp Glu His

C19H28N6O10 (500.1867)

Thr Asp His Glu

C19H28N6O10 (500.1867)

Thr Glu Asp His

C19H28N6O10 (500.1867)

Thr Glu His Asp

C19H28N6O10 (500.1867)

Thr Phe Ala Tyr

C25H32N4O7 (500.2271)

Thr Phe Phe Ser

C25H32N4O7 (500.2271)

Thr Phe Ser Phe

C25H32N4O7 (500.2271)

Thr Phe Tyr Ala

C25H32N4O7 (500.2271)

Thr His Asp Glu

C19H28N6O10 (500.1867)

Thr His Glu Asp

C19H28N6O10 (500.1867)

Thr Met Ser Tyr

C21H32N4O8S (500.1941)

Thr Met Tyr Ser

C21H32N4O8S (500.1941)

Thr Ser Phe Phe

C25H32N4O7 (500.2271)

Thr Ser Met Tyr

C21H32N4O8S (500.1941)

Thr Ser Tyr Met

C21H32N4O8S (500.1941)

Thr Tyr Ala Phe

C25H32N4O7 (500.2271)

Thr Tyr Phe Ala

C25H32N4O7 (500.2271)

Thr Tyr Met Ser

C21H32N4O8S (500.1941)

Thr Tyr Ser Met

C21H32N4O8S (500.1941)

Val Asp His Met

C20H32N6O7S (500.2053)

Val Asp Met His

C20H32N6O7S (500.2053)

Val Gly Tyr Tyr

C25H32N4O7 (500.2271)

Val His Asp Met

C20H32N6O7S (500.2053)

Val His Met Asp

C20H32N6O7S (500.2053)

Val Met Asp His

C20H32N6O7S (500.2053)

Val Met His Asp

C20H32N6O7S (500.2053)

Val Tyr Gly Tyr

C25H32N4O7 (500.2271)

Val Tyr Tyr Gly

C25H32N4O7 (500.2271)

Tyr Ala Phe Thr

C25H32N4O7 (500.2271)

Tyr Ala Thr Phe

C25H32N4O7 (500.2271)

Tyr Asp Phe Gly

C24H28N4O8 (500.1907)

Tyr Asp Gly Phe

C24H28N4O8 (500.1907)

Tyr Phe Ala Thr

C25H32N4O7 (500.2271)

Tyr Phe Asp Gly

C24H28N4O8 (500.1907)

Tyr Phe Gly Asp

C24H28N4O8 (500.1907)

Tyr Phe Thr Ala

C25H32N4O7 (500.2271)

Tyr Gly Asp Phe

C24H28N4O8 (500.1907)

Tyr Gly Phe Asp

C24H28N4O8 (500.1907)

Tyr Gly Val Tyr

C25H32N4O7 (500.2271)

Tyr Gly Tyr Val

C25H32N4O7 (500.2271)

Tyr Met Ser Thr

C21H32N4O8S (500.1941)

Tyr Met Thr Ser

C21H32N4O8S (500.1941)

Tyr Ser Met Thr

C21H32N4O8S (500.1941)

Tyr Ser Thr Met

C21H32N4O8S (500.1941)

Tyr Thr Ala Phe

C25H32N4O7 (500.2271)

Tyr Thr Phe Ala

C25H32N4O7 (500.2271)

Tyr Thr Met Ser

C21H32N4O8S (500.1941)

Tyr Thr Ser Met

C21H32N4O8S (500.1941)

Tyr Val Gly Tyr

C25H32N4O7 (500.2271)

Tyr Val Tyr Gly

C25H32N4O7 (500.2271)

Tyr Tyr Gly Val

C25H32N4O7 (500.2271)

Tyr Tyr Val Gly

C25H32N4O7 (500.2271)

Flutide

C25H31F3O5S (500.1844)

punaglandin 6

C25H37ClO8 (500.2177)

Isoaustin

C27H32O9 (500.2046)

punaglandin 6

C25H37O8Cl (500.2177)

rolapitant

C25H26F6N2O2 (500.1898)

A - Alimentary tract and metabolism > A04 - Antiemetics and antinauseants > A04A - Antiemetics and antinauseants D018377 - Neurotransmitter Agents > D064729 - Neurokinin-1 Receptor Antagonists C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Rolapitant (SCH619734) is a potent, selective, long-acting and orally active neurokinin 1 (NK1) receptor antagonist with a Ki of 0.66 nM. Rolapitant does not interact with CYP3A4. Rolapitant shows potent anti-emetic activity in a ferret emesis model[1][2].

boc-lys(z)-pna

C25H32N4O7 (500.2271)

Vinmegallate-d9

C30H32N2O5 (500.2311)

N-Desmethyl Telmisartan

C32H28N4O2 (500.2212)

Dovitinib lactate

C24H29FN6O5 (500.2183)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

Gliflumide

C25H29FN4O4S (500.1893)

β-​Alanine, N-​[[2-​[[[4-​(aminocarbonyl)​phenyl]​amino]​methyl]​-​1-​methyl-​1H-​benzimidazol-​5-​yl]​carbonyl]​-​N-​2-​pyridinyl-​, ethyl ester

C27H28N6O4 (500.2172)

H-D-Phe-Phe-Arg-chloromethylketone trifluoroacetate salt

C25H33ClN6O3 (500.2303)

BOC-N-ME-ARG(MTR)-OH

C22H36N4O7S (500.2305)

Biotin-PEG2-NHS ester

C21H32N4O8S (500.1941)

(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide

C26H33FN4O3S (500.2257)

C274 - Antineoplastic Agent > C129839 - Apoptotic Pathway-targeting Antineoplastic Agent

Managlinat dialanetil

C21H33N4O6PS (500.1858)

C471 - Enzyme Inhibitor

(1S,3S)-3-ethyl-3,5,10,12-tetrahydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-azaniumyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside

C26H30NO9+ (500.192)

(2S)-3-hydroxy-2-[[1-[[(2R)-2-[(1R)-2-methoxy-2-oxo-1-phenylethyl]piperidine-1-carbonyl]oxymethyl]pyridin-1-ium-3-carbonyl]amino]propanoic acid

C25H30N3O8+ (500.2033)

2-amino-N-[2-[[1-chloro-6-(diaminomethylideneamino)-2-oxohexan-3-yl]amino]-3-phenylpropanoyl]-3-phenylpropanamide

C25H33ClN6O3 (500.2303)

decanoyl-AMP

C20H31N5O8P- (500.191)

(2S)-2-[(4R,5S)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C27H33FN2O4S (500.2145)

rhodamine B 6-isothiocyanate

C29H30N3O3S+ (500.2008)

N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C25H32N4O5S (500.2093)

6,9-difluoro-11-hydroxy-17-(3-hydroxy-2-oxopropyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioic acid S-(fluoromethyl) ester

C25H31F3O5S (500.1844)

(2R)-2-[(4S,5R)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C27H33FN2O4S (500.2145)

N-[[(4R,5S)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C25H32N4O5S (500.2093)

N-[[(4S,5S)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C25H32N4O5S (500.2093)

N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C25H32N4O5S (500.2093)

N-[[(4S,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C25H32N4O5S (500.2093)

N-[[(2S,3R)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C27H28N6O4 (500.2172)

2-[(1S,3S,4aS,9aR)-6-(benzenesulfonamido)-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-cyclohexylacetamide

C26H32N2O6S (500.1981)

(1R)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-2-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide

C29H29FN4O3 (500.2224)

(2S)-2-[(4S,5R)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C27H33FN2O4S (500.2145)

(2R)-2-[(4R,5S)-5-[[cyclopropylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol

C27H33FN2O4S (500.2145)

N-[[(4R,5R)-8-(1-cyclopentenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C25H32N4O5S (500.2093)

N-[[(4S,5S)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C25H32N4O5S (500.2093)

N-[[(4R,5R)-8-(1-cyclopentenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C25H32N4O5S (500.2093)

N-[[(2S,3S)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C27H28N6O4 (500.2172)

N-[[(2S,3S)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C27H28N6O4 (500.2172)

N-[[(2R,3S)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C27H28N6O4 (500.2172)

N-[[(2R,3R)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C27H28N6O4 (500.2172)

N-[[(2R,3R)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C27H28N6O4 (500.2172)

N-[[(2S,3R)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C27H28N6O4 (500.2172)

N-[[(2R,3S)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-pyrazinecarboxamide

C27H28N6O4 (500.2172)

2-[(3R,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(4-phenylphenyl)acetamide

C30H32N2O5 (500.2311)

(1S)-N-(3-fluorophenyl)-1-(hydroxymethyl)-7-methoxy-2-(phenylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide

C29H29FN4O3 (500.2224)

9-(2-Carboxy-4-isothiocyanatophenyl)-3,6-bis(diethylamino)xanthylium

C29H30N3O3S+ (500.2008)

CID 101290239

C27H32O9 (500.2046)

Fluticasone propionate (Flonase, Veramyst)

C25H31F3O5S (500.1844)

7-amino-4,5,6-triethoxy-3-(9-methoxy-6-methyl-7,8-dihydro-5H-[1,3]dioxolo[4,5-g]isoquinolin-7-yl)-3H-2-benzofuran-1-one

C26H32N2O8 (500.2159)

13-deoxycarminomycin(1+)

C26H30NO9 (500.192)

An anthracyline cation that is the conjugate acid of 13-deoxycarminomycin, obtained by protonation of the amino group. Major microspecies at pH 7.3

SQMG 12:0

C21H40O11S (500.2291)

PM 20:5;O

C24H37O9P (500.2175)

ST 18:1;O5;GlcA

C24H36O11 (500.2258)

ST 21:6;O3;GlcA

C27H32O9 (500.2046)

ST 18:2;O6;Hex

C24H36O11 (500.2258)

ST 24:3;O6;S

C24H36O9S (500.208)

ST 28:7;O3;S

C28H36O6S (500.2232)

ELN-441958

C29H29ClN4O2 (500.1979)

ELN-441958 is a potent, neutral, competitive and selective bradykinin B1 receptor antagonist with a Ki of 0.26 nM against native human bradykinin B1 receptor. ELN-441958 has high oral bioavailability, and has low CNS exposure in the mouse[1].

(1s,2s,3r,7s,8s,9r,13s)-3,8-dimethyl-13-{[(2z)-2-methylbut-2-enoyl]oxy}-12-methylidene-4,11-dioxo-10-oxatricyclo[7.3.1.0³,⁷]tridec-5-en-2-yl (2z)-2-[(acetyloxy)methyl]but-2-enoate

C27H32O9 (500.2046)

3,9-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl 2-methylbut-2-enoate

C27H32O9 (500.2046)

(12r)-3,10,17-trihydroxy-7,7,21,21-tetramethyl-12-(prop-1-en-2-yl)-8,20,26-trioxahexacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-1(14),2,4(9),5,10,16,18,22,24-nonaen-15-one

C30H28O7 (500.1835)

12'-hydroxy-2,2,2',6',9',13'-hexamethyl-16'-methylidene-6,11',15'-trioxo-10',14'-dioxaspiro[pyran-3,5'-tetracyclo[7.6.1.0¹,¹².0²,⁷]hexadecan]-6'-en-8'-yl acetate

C27H32O9 (500.2046)

methyl 2-[6-(furan-3-yl)-11-hydroxy-1,5,15,15-tetramethyl-8,14,17-trioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-9-en-16-yl]-2-hydroxyacetate

C27H32O9 (500.2046)

(8s,9r,10s)-3,9-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl (2e)-2-methylbut-2-enoate

C27H32O9 (500.2046)

(6s)-2-[2-(4-hydroxyphenyl)ethyl]-6-[2-(4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]-5,6-dihydropyran-4-one

C27H32O9 (500.2046)

27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione

C27H32O9 (500.2046)

methyl (2e)-3-[(1s,2r,4s,7s,8s,11r,12s,16r,18r)-7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate

C27H32O9 (500.2046)

(4r,7r,7ar)-3,7a-dibenzyl-4-hydroxy-4,7-diphenyl-6,7-dihydro-1-benzofuran-2,5-dione

C34H28O4 (500.1987)

(9r)-8-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-9-[(4-methoxyphenyl)methyl]-9h-xanthene-2,3,6-triol

C30H28O7 (500.1835)

(12'z,18'z,20'z)-6'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione

C27H32O9 (500.2046)

(8r,9r,10r)-9-hydroxy-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl but-2-enoate

C27H32O9 (500.2046)

2-{3-[(2s)-2,3-dihydroxy-3-methylbutyl]-4-hydroxy-5-(3-methylbut-2-en-1-yl)phenyl}-5,7-dihydroxy-3,6-dimethoxychromen-4-one

C27H32O9 (500.2046)

3,8-dimethyl-13-[(2-methylbut-2-enoyl)oxy]-12-methylidene-4,11-dioxo-10-oxatricyclo[7.3.1.0³,⁷]tridec-5-en-2-yl 2-[(acetyloxy)methyl]but-2-enoate

C27H32O9 (500.2046)

(1'r,2s,3'r,8'r,12'e,18'e,20'e,24's,25's,27'r)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione

C27H32O9 (500.2046)

(1'r,2s,3'r,8'r,12'z,18'e,20'z,24's,25's,27'r)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione

C27H32O9 (500.2046)

15-(2-hydroxy-2-methylpropyl)-4,13,13,18-tetramethyl-12,26-dioxa-4,18-diazahexacyclo[12.12.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-2(11),5,7,9,16(25),19,21,23-octaene-3,17-dione

C30H32N2O5 (500.2311)

(1'r,2r,3'r,8'r,13'r,18'e,20'z,24'r,25's)-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',12',17',22'-tetrone

C27H32O9 (500.2046)

methyl (2e)-3-[(1s,2r,4s,7s,8s,11r,12s,16r,18s)-7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate

C27H32O9 (500.2046)

[(2s,3s,4s,5r)-3,4,5-trihydroxy-6-[(2s)-3-(octanoyloxy)-2-(propanoyloxy)propoxy]oxan-2-yl]methanesulfonic acid

C20H36O12S (500.1927)

methyl 3-[7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate

C27H32O9 (500.2046)

methyl 3-[11'-(furan-3-yl)-3'-hydroxy-2',3,3,6',10'-pentamethyl-4',13'-dioxo-12',15'-dioxaspiro[oxirane-2,5'-tetracyclo[8.5.0.0¹,¹⁴.0²,⁷]pentadecan]-6'-yl]prop-2-enoate

C27H32O9 (500.2046)

13,15-dimethyl (1s,2r,6r,14s,15r,16r,18s,20s)-20-ethoxy-15-hydroxy-11-methoxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate

C26H32N2O8 (500.2159)

atalantin

C27H32O9 (500.2046)

{"Ingredient_id": "HBIN017265","Ingredient_name": "atalantin","Alias": "NA","Ingredient_formula": "C27H32O9","Ingredient_Smile": "CC1(C2C(=O)C(C3(C(C2(CO1)C=CC(=O)OC)CCC4(C35C(O5)C(=O)OC4C6=COC=C6)C)C)O)C","Ingredient_weight": "500.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1955","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101593045","DrugBank_id": "NA"}

[(1s,2s,4s,5r,6s,7s,9r,12r)-4,5,7-tris(acetyloxy)-2,12-dihydroxy-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl acetate

C23H32O12 (500.1894)

(1'r,3'r,6's,8'r,12'e,18'e,20'z,24'r,25's)-6'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione

C27H32O9 (500.2046)

(2s)-2-{[(2e,4e,6e,8e,10e,12e,14e)-15-{[(1s,2s)-1-carboxy-2-methylbutyl]-c-hydroxycarbonimidoyl}-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]amino}butanedioic acid

C26H32N2O8 (500.2159)

3-[(2r,3r)-2-(furan-3-yl)-4-{2-[(4r,5r)-4-(2-methoxy-2-oxoethyl)-3,3,5-trimethyl-6-oxocyclohex-1-en-1-yl]acetyl}-3-methyl-6-oxo-2h-pyran-3-yl]propanoic acid

C27H32O9 (500.2046)

(3r,4r,5s,7r)-4-hydroxy-3-[(2-methylpropanoyl)oxy]-6-(prop-2-en-1-yl)-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-9(16),10,12,14-tetraen-7-yl (2e)-3-phenylprop-2-enoate

C30H32N2O5 (500.2311)

(1r,3s,7r,16s,17r,20z,23z)-28-hydroxy-10,16-dimethyl-2,5,13,18,25-pentaoxaspiro[hexacyclo[22.3.1.1¹⁴,¹⁷.0¹,³.0⁷,¹².0⁷,¹⁶]nonacosane-15,2'-oxirane]-10,20,23-triene-4,19-dione

C27H32O9 (500.2046)

(1r,2s,3r)-2-(3,5-dihydroxyphenyl)-1-[(r)-ethoxy(4-hydroxyphenyl)methyl]-3-(4-hydroxyphenyl)-2,3-dihydro-1h-indene-4,6-diol

C30H28O7 (500.1835)

methyl (2z)-3-[(1s,2r,4s,7s,8s,11r,12r,16s,18r)-7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate

C27H32O9 (500.2046)

methyl 2-[(1s,2s,8r,9s,10s,11s,13r,14r,17r)-14-(furan-3-yl)-11,17-dihydroxy-2,7,7,9,13-pentamethyl-6,16-dioxo-3,15-dioxapentacyclo[8.7.0.0¹,¹³.0²,¹⁰.0⁴,⁹]heptadec-4-en-8-yl]acetate

C27H32O9 (500.2046)

(2e)-3-{[(3ar,4r,6ar,9s,9ar,9br)-9-methyl-3,6-dimethylidene-2,8-dioxo-octahydroazuleno[4,5-b]furan-4-yl]oxy}-2-ethylidene-3-oxopropyl (2e)-2-[(acetyloxy)methyl]but-2-enoate

C27H32O9 (500.2046)

[(2r,3r,4r,5r,6s)-3,4,5-tris(acetyloxy)-6-{[(1s,6s)-6-hydroxy-3-isopropyl-6-methylcyclohex-2-en-1-yl]oxy}oxan-2-yl]methyl acetate

C24H36O11 (500.2258)

(18'e)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione

C27H32O9 (500.2046)

(1s,2r,5s,6s,7s,9r,12r)-5-(acetyloxy)-12-(furan-3-carbonyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl furan-3-carboxylate

C27H32O9 (500.2046)

(5r,5ar,6as,6bs,10ar,11r,12as,12bs,12cs)-10a-chloro-5a,11-dihydroxy-3,3',4',6b,12c-pentamethyl-2,6,6a,10,11,12,12a,12b-octahydro-1h-spiro[cyclohexa[j]aceanthrylene-5,2'-furan]-4,5',7-trione

C28H33ClO6 (500.1966)

(1r,7r,12r,14r,15s,16s,17r,20z,24s,28s)-10,16-dimethyl-2,5,13,18,25,29-hexaoxaspiro[heptacyclo[22.3.2.1¹⁴,¹⁷.0¹,³.0⁷,¹².0⁷,¹⁶.0²⁴,²⁸]triacontane-15,2'-oxirane]-10,20-diene-4,19-dione

C27H32O9 (500.2046)

(2s)-2-{[(9h-fluoren-9-ylmethoxy)(hydroxy)methylidene]amino}-n-[(2s)-1-methoxy-1-oxo-3-phenylpropan-2-yl]-3-methylbutanimidic acid

C30H32N2O5 (500.2311)

1-(3,5-dihydroxy-2-{[(4-methoxy-4-oxobutan-2-yl)oxy]carbonyl}phenyl)propan-2-yl 4-hydroxy-3-[(3-hydroxybutanoyl)oxy]butanoate

C23H32O12 (500.1894)

(1s,2r,5s,6s,7s,9r,12r)-5-(acetyloxy)-12-(furan-2-carbonyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl furan-2-carboxylate

C27H32O9 (500.2046)

(1's,2'r,3s,4's,9's,12's,13's)-12'-hydroxy-2,2,2',6',9',13'-hexamethyl-16'-methylidene-6,11',15'-trioxo-10',14'-dioxaspiro[pyran-3,5'-tetracyclo[7.6.1.0¹,¹².0²,⁷]hexadecan]-6'-en-4'-yl acetate

C27H32O9 (500.2046)

2-({15-[(1-carboxy-2-methylbutyl)-c-hydroxycarbonimidoyl]-1-hydroxypentadeca-2,4,6,8,10,12,14-heptaen-1-ylidene}amino)butanedioic acid

C26H32N2O8 (500.2159)

methyl 2-[(1s,3s,7s,8r,10r,11s,12s,13s)-13-(furan-3-yl)-11-hydroxy-6,6,8,12-tetramethyl-17-methylidene-5,9,15-trioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

C27H32O9 (500.2046)

(3as,4s,4ar,7as,8s,9r,9as)-4a,8-dimethyl-9-{[(2z)-2-methylbut-2-enoyl]oxy}-3-methylidene-2,5-dioxo-3ah,4h,7ah,8h,9h,9ah-azuleno[6,5-b]furan-4-yl (2z)-2-[(acetyloxy)methyl]but-2-enoate

C27H32O9 (500.2046)

methyl (2r,2'r,3s,4'as,5's,6's,8'ar)-2'-(furan-3-carbonyl)-5'-hydroxy-2',2'',2'',5',8'a-pentamethyl-6'',8'-dioxo-3',4',4'a,7'-tetrahydrodispiro[oxirane-2,1'-naphthalene-6',3''-pyran]-3-carboxylate

C27H32O9 (500.2046)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s,6r)-2-{[(2r)-2-[(5z)-hept-5-en-1,3-diyn-1-yl]oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C23H32O12 (500.1894)

4a,8-dimethyl-9-[(2-methylbut-2-enoyl)oxy]-3-methylidene-2,5-dioxo-3ah,4h,7ah,8h,9h,9ah-azuleno[6,5-b]furan-4-yl 2-[(acetyloxy)methyl]but-2-enoate

C27H32O9 (500.2046)

(1s,12r,13r,14s,15r)-15-hydroxy-18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4(21),5(9),10,16,18-pentaen-12-yl (2r)-2-methylbutanoate

C27H32O9 (500.2046)

methyl (2s,3r,4r,5s,8r)-4-{2-[(3e)-2,2-dimethyl-6-oxopyran-3-ylidene]acetyl}-8-(furan-3-carbonyl)-5-[(1r)-1-hydroxyethyl]-4,8-dimethyl-1-oxaspiro[2.5]octane-2-carboxylate

C27H32O9 (500.2046)

methyl 2-[13-(furan-3-yl)-1,3-dihydroxy-4,6,14-trimethyl-7,11-dioxo-9,12-dioxahexacyclo[8.7.1.1³,⁶.0²,⁸.0⁴,¹⁷.0¹⁴,¹⁸]nonadecan-5-yl]acetate

C27H32O9 (500.2046)

12'-hydroxy-2,2,2',6',9',13'-hexamethyl-16'-methylidene-6,11',15'-trioxo-10',14'-dioxaspiro[pyran-3,5'-tetracyclo[7.6.1.0¹,¹².0²,⁷]hexadecan]-6'-en-4'-yl acetate

C27H32O9 (500.2046)

methyl 4-[2-(2,2-dimethyl-6-oxopyran-3-ylidene)acetyl]-8-(furan-3-carbonyl)-5-(1-hydroxyethyl)-4,8-dimethyl-1-oxaspiro[2.5]octane-2-carboxylate

C27H32O9 (500.2046)

methyl 2-[14-(furan-3-yl)-17-hydroxy-2,7,7,9,13-pentamethyl-6,16-dioxo-3,15-dioxapentacyclo[8.7.0.0¹,¹³.0²,¹⁰.0⁴,⁹]heptadec-4-en-8-yl]-2-hydroxyacetate

C27H32O9 (500.2046)

(2s,3r,4s,5s,6r)-2-{[(2s,3r,4s,5s,6r)-2-{[(2r)-2-[(5e)-hept-5-en-1,3-diyn-1-yl]oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C23H32O12 (500.1894)

[4,5,7-tris(acetyloxy)-2,12-dihydroxy-2,10,10-trimethyl-8-oxo-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-6-yl]methyl acetate

C23H32O12 (500.1894)

2-{[(9h-fluoren-9-ylmethoxy)(hydroxy)methylidene]amino}-n-(1-methoxy-1-oxo-3-phenylpropan-2-yl)-3-methylbutanimidic acid

C30H32N2O5 (500.2311)

(1r,2r,4s,5s,6r,7s,9s,10r,11s,13r,15r)-2-(acetyloxy)-1,5,7,10,11-pentahydroxy-4,12,12,15-tetramethyl-8-methylidene-14-oxo-16-oxatricyclo[11.2.1.0²,⁶]hexadecan-9-yl acetate

C24H36O11 (500.2258)

methyl 2-[(1s,2r,3s,4s,5r,6r,8r,10s,13r,14r,17r,18s)-13-(furan-3-yl)-1,3-dihydroxy-4,6,14-trimethyl-7,11-dioxo-9,12-dioxahexacyclo[8.7.1.1³,⁶.0²,⁸.0⁴,¹⁷.0¹⁴,¹⁸]nonadecan-5-yl]acetate

C27H32O9 (500.2046)

5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',18',20'-triene-11',12',17',22'-tetrone

C27H32O9 (500.2046)

(1'r,2s,3'r,8'r,12'e,18'e,20'z,24's,25's,27'r)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione

C27H32O9 (500.2046)

methyl 2-[14-(furan-3-yl)-2,17-dihydroxy-2,7,7,9,13-pentamethyl-6,16-dioxo-3,15-dioxatetracyclo[8.7.0.0¹,¹³.0⁴,⁹]heptadeca-4,10-dien-8-yl]acetate

C27H32O9 (500.2046)

5-(acetyloxy)-12-(furan-3-carbonyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl furan-3-carboxylate

C27H32O9 (500.2046)

methyl (2r)-2-[(1s,2r,5r,6r,11r,13s,16s)-6-(furan-3-yl)-11-hydroxy-1,5,15,15-tetramethyl-8,14,17-trioxo-7-oxatetracyclo[11.3.1.0²,¹¹.0⁵,¹⁰]heptadec-9-en-16-yl]-2-hydroxyacetate

C27H32O9 (500.2046)

15-hydroxy-18,19-dimethoxy-13,14-dimethyl-20-oxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4(21),5(9),10,16,18-pentaen-12-yl 2-methylbutanoate

C27H32O9 (500.2046)

3-[(3s)-3-{[(2r,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}butyl]-3h-2-benzofuran-1-one

C23H32O12 (500.1894)

(9s,10s,11s)-3,10-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(19),2(7),3,5,12,14(18)-hexaen-11-yl (2z)-2-methylbut-2-enoate

C27H32O9 (500.2046)

11,17-dihydroxy-7,7,20,20-tetramethyl-4-(3-methylbut-2-en-1-yl)-2,6,19,25-tetraoxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²⁴.0¹⁸,²³]pentacosa-1(14),3,5(10),8,11,15(24),16,18(23),21-nonaen-13-one

C30H28O7 (500.1835)

(8r,9r,10r)-9-hydroxy-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl (2z)-but-2-enoate

C27H32O9 (500.2046)

3,10-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(19),2(7),3,5,12,14(18)-hexaen-11-yl 2-methylbut-2-enoate

C27H32O9 (500.2046)

[(2r,3r,4s)-6-(acetyloxy)-3-[(acetyloxy)methyl]-4-(3,4-dimethoxyphenyl)-7-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methyl acetate

C27H32O9 (500.2046)

5,13,17,19-tetrahydroxy-22,22-dimethyl-15-oxo-7-pentylpentacyclo[12.8.0.0³,¹².0⁴,⁹.0¹⁶,²¹]docosa-1,3(12),4(9),5,7,10,13,16,18,20-decaene-6-carboxylic acid

C30H28O7 (500.1835)

10a-chloro-5a,11-dihydroxy-3,3',4',6b,12c-pentamethyl-2,6,6a,10,11,12,12a,12b-octahydro-1h-spiro[cyclohexa[j]aceanthrylene-5,2'-furan]-4,5',7-trione

C28H33ClO6 (500.1966)

[(3s,4s,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl (2e)-hex-2-enoate

C23H32O12 (500.1894)

3-[2-(furan-3-yl)-4-{2-[4-(2-methoxy-2-oxoethyl)-3,3,5-trimethyl-6-oxocyclohex-1-en-1-yl]acetyl}-3-methyl-6-oxo-2h-pyran-3-yl]propanoic acid

C27H32O9 (500.2046)

methyl (2z)-3-[(1'r,2s,2's,3'r,6'r,7'r,10's,11's,14's)-11'-(furan-3-yl)-3'-hydroxy-2',3,3,6',10'-pentamethyl-4',13'-dioxo-12',15'-dioxaspiro[oxirane-2,5'-tetracyclo[8.5.0.0¹,¹⁴.0²,⁷]pentadecan]-6'-yl]prop-2-enoate

C27H32O9 (500.2046)

[3,4,5-tris(acetyloxy)-6-[(6-hydroxy-3-isopropyl-6-methylcyclohex-2-en-1-yl)oxy]oxan-2-yl]methyl acetate

C24H36O11 (500.2258)

{1-[4-(acetyloxy)-3-methoxyphenyl]-3-[(acetyloxy)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl}methyl acetate

C27H32O9 (500.2046)

(5-{[4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl)methyl hex-2-enoate

C23H32O12 (500.1894)

(4s)-4-({[(6r)-6-[(1r)-2-(2-aminophenyl)-1-methoxy-2-oxoethyl]-1,4-dimethyl-5-oxo-6h-pyrazin-2-yl](hydroxy)methylidene}amino)-7-methyl-5-oxooct-6-enoic acid

C25H32N4O7 (500.2271)

(12s)-3,10,17-trihydroxy-7,7,21,21-tetramethyl-12-(prop-1-en-2-yl)-8,20,26-trioxahexacyclo[12.12.0.0²,¹¹.0⁴,⁹.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-1(14),2,4(9),5,10,16,18,22,24-nonaen-15-one

C30H28O7 (500.1835)

(1'r,3'r,18'e,20'e)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione

C27H32O9 (500.2046)

4-deacylwallifoliol

C27H32O9 (500.2046)

3-[2-(furan-3-yl)-4-[4-hydroxy-6-(2-methoxy-2-oxoethyl)-5,5,7-trimethyl-6,7-dihydro-4h-1-benzofuran-2-yl]-3-methyl-6-oxo-2h-pyran-3-yl]propanoic acid

C27H32O9 (500.2046)

[3,4,5-tris(acetyloxy)-6-[(6-hydroxy-2,6-dimethylocta-2,7-dien-1-yl)oxy]oxan-2-yl]methyl acetate

C24H36O11 (500.2258)

methyl 2'-(furan-3-carbonyl)-5'-hydroxy-2',2'',2'',5',8'a-pentamethyl-6'',8'-dioxo-3',4',4'a,7'-tetrahydrodispiro[oxirane-2,1'-naphthalene-6',3''-pyran]-3-carboxylate

C27H32O9 (500.2046)

(1'r,2s,3'r,8'r,24's,25's,27'r)-27'-hydroxy-5',13',25'-trimethyl-2',10',16',23'-tetraoxaspiro[oxirane-2,26'-tetracyclo[22.2.1.0³,⁸.0⁸,²⁵]heptacosane]-4',12',18',20'-tetraene-11',17',22'-trione

C27H32O9 (500.2046)

(1s,14r,15r)-15-(2-hydroxy-2-methylpropyl)-4,13,13,18-tetramethyl-12,26-dioxa-4,18-diazahexacyclo[12.12.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁵.0¹⁹,²⁴]hexacosa-2(11),5,7,9,16(25),19,21,23-octaene-3,17-dione

C30H32N2O5 (500.2311)

methyl 2-[(1r,2s,8r,9s,13r,14r,17r)-14-(furan-3-yl)-2,17-dihydroxy-2,7,7,9,13-pentamethyl-6,16-dioxo-3,15-dioxatetracyclo[8.7.0.0¹,¹³.0⁴,⁹]heptadeca-4,10-dien-8-yl]acetate

C27H32O9 (500.2046)

methyl (2r)-2-[(1s,2s,8r,9s,10s,13r,14r,17r)-14-(furan-3-yl)-17-hydroxy-2,7,7,9,13-pentamethyl-6,16-dioxo-3,15-dioxapentacyclo[8.7.0.0¹,¹³.0²,¹⁰.0⁴,⁹]heptadec-4-en-8-yl]-2-hydroxyacetate

C27H32O9 (500.2046)

9-(acetyloxy)-1,5,7,10,11-pentahydroxy-4,12,12,15-tetramethyl-8-methylidene-14-oxo-16-oxatricyclo[11.2.1.0²,⁶]hexadecan-2-yl acetate

C24H36O11 (500.2258)

2-[(2-{[2-(hept-5-en-1,3-diyn-1-yl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C23H32O12 (500.1894)

methyl 2-[14-(furan-3-yl)-11,17-dihydroxy-2,7,7,9,13-pentamethyl-6,16-dioxo-3,15-dioxapentacyclo[8.7.0.0¹,¹³.0²,¹⁰.0⁴,⁹]heptadec-4-en-8-yl]acetate

C27H32O9 (500.2046)

3-[(2r,3r)-2-(furan-3-yl)-4-[(4r,6r,7r)-4-hydroxy-6-(2-methoxy-2-oxoethyl)-5,5,7-trimethyl-6,7-dihydro-4h-1-benzofuran-2-yl]-3-methyl-6-oxo-2h-pyran-3-yl]propanoic acid

C27H32O9 (500.2046)

(4s)-4-({[(6r)-6-[(1s)-2-(2-aminophenyl)-1-methoxy-2-oxoethyl]-1,4-dimethyl-5-oxo-6h-pyrazin-2-yl](hydroxy)methylidene}amino)-7-methyl-5-oxooct-6-enoic acid

C25H32N4O7 (500.2271)

6,14,15-trihydroxy-7-methyl-10-oxo-12-(2-oxoheptyl)-4-pentyl-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaene-5-carboxylic acid

C27H32O9 (500.2046)

4-{[1-(3,5-dihydroxy-2-{[(4-methoxy-4-oxobutan-2-yl)oxy]carbonyl}phenyl)propan-2-yl]oxy}-4-oxobutan-2-yl 3,4-dihydroxybutanoate

C23H32O12 (500.1894)

[6-(acetyloxy)-3-[(acetyloxy)methyl]-4-(3,4-dimethoxyphenyl)-7-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methyl acetate

C27H32O9 (500.2046)

(8s,9r,10r)-3,9-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl (2z)-2-methylbut-2-enoate

C27H32O9 (500.2046)

methyl 2-[13-(furan-3-yl)-11-hydroxy-6,6,8,12-tetramethyl-17-methylidene-5,9,15-trioxo-2,14-dioxatetracyclo[8.6.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

C27H32O9 (500.2046)

[(1s,2r,3r)-1-[4-(acetyloxy)-3-methoxyphenyl]-3-[(acetyloxy)methyl]-6,7-dimethoxy-1,2,3,4-tetrahydronaphthalen-2-yl]methyl acetate

C27H32O9 (500.2046)

[(2r,3r,4s,5r,6r)-3,4,5-tris(acetyloxy)-6-{[(2z,6s)-6-hydroxy-2,6-dimethylocta-2,7-dien-1-yl]oxy}oxan-2-yl]methyl acetate

C24H36O11 (500.2258)

(9r,10s,11s)-3,10-dihydroxy-4,5,19-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(19),2(7),3,5,12,14(18)-hexaen-11-yl (2z)-2-methylbut-2-enoate

C27H32O9 (500.2046)

methyl (2z)-3-[(1s,2r,4s,7s,8s,11r,12s,16r,18r)-7-(furan-3-yl)-18-hydroxy-1,8,15,15-tetramethyl-5,17-dioxo-3,6,14-trioxapentacyclo[9.7.0.0²,⁴.0²,⁸.0¹²,¹⁶]octadecan-12-yl]prop-2-enoate

C27H32O9 (500.2046)

(8s,9s,10s)-9,19-dihydroxy-3,4,5-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl (2e)-2-methylbut-2-enoate

C27H32O9 (500.2046)

2-[2-(4-hydroxyphenyl)ethyl]-6-[2-(4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)ethyl]-5,6-dihydropyran-4-one

C27H32O9 (500.2046)

9-methyl-3,6-dimethylidene-2,8-dioxo-octahydroazuleno[4,5-b]furan-4-yl 2-[({2-[(acetyloxy)methyl]but-2-enoyl}oxy)methyl]but-2-enoate

C27H32O9 (500.2046)

(8s,9s,10s)-9,19-dihydroxy-3,4,5-trimethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2,4,6,13,18-hexaen-8-yl 2-methylbut-2-enoate

C27H32O9 (500.2046)

[(3r,4s,5r)-5-{[(2r,3s,4r,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl (2e)-hex-2-enoate

C23H32O12 (500.1894)

[(3s,4r,5s)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-2-(4-hydroxyphenoxy)oxan-3-yl]oxy}-3,4-dihydroxyoxolan-3-yl]methyl (2e)-hex-2-enoate

C23H32O12 (500.1894)